Seres Therapeutics
MCRB
MCRB
99 hedge funds and large institutions have $66.8M invested in Seres Therapeutics in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 28 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
14% less call options, than puts
Call options by funds: $408K | Put options by funds: $477K
47% less capital invested
Capital invested by funds: $127M → $66.8M (-$60.3M)
Holders
99
Holding in Top 10
1
Calls
$408K
Puts
$477K
Top Buyers
| 1 | +$2.53M | |
| 2 | +$855K | |
| 3 | +$585K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$565K |
| 5 |
Goldman Sachs
New York
|
+$486K |
Top Sellers
| 1 | -$3.01M | |
| 2 | -$1.14M | |
| 3 | -$1M | |
| 4 |
Millennium Management
New York
|
-$926K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$897K |